Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLO-ASC-DFU in Diabetic Foot Ulcers
NCT03370874Phase 3Completed
- Sponsor
- Anterogen Co., Ltd.
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of allo-asc in diabetic foot ulcer (DFU), sponsored by Anterogen Co., Ltd.. Started Jun 2018; status: completed.
02
Drugs
allo-asc
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03370874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03370874.